powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1083001275
Daniel Aridgides
M.D. PH.D.
Pulmonary Disease
Lebanon,
NH
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CCN 300003
Hospital
CCN 300019
Hospital
CCN 301304
Hospital
CCN 301305
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
532
Beneficiaries
—
Total drug cost
$2.8M
Distinct drugs
17
Brand share
66.0%
Top prescribed drugs
Elexacaftor/Tezacaftor/Ivacaft
102 claims
Prednisone
59 claims
Azithromycin
52 claims
Albuterol Sulfate
49 claims
Fluticasone Propion/Salmeterol
35 claims
QUALITY · MIPS · 2024
Final MIPS score
79.7
Quality
53.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.20%
APM Entity
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
474
Unique beneficiaries
—
Total services
562
Distinct HCPCS
9
Medicare payment
$29K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 67 Pulmonary Disease providers in NH — below median (cohort median 823).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.